BioCorRx Provides Business Update for 2022

April 3, 2023

Revenue Increases 343% for 2022 Due to Increased Number of Patients Treated at Licensed Clinics

ANAHEIM, CA, April 03, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB:BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the year ended December 31, 2022 and reported on recent corporate developments.

Read more at globenewswire.com

Related news for (BICX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.